MF 03
Alternative Names: MF-03Latest Information Update: 14 Jul 2023
At a glance
- Originator MetaFines
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Acidosis
Most Recent Events
- 14 Jul 2023 Early research in Acidosis (Chemotherapy-induced) in South Korea (unspecified route) before July 2023 (MetaFines pipeline, July 2023)